Massey Cancer Center, Virginia Commonwealth University is a clinical research site located in Richmond, Virginia, United States 23298-0037.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Massey Cancer Center, Virginia Commonwealth University has participated in 4 clinical trials.
Therapeutic areas: Epithelial Cancer, Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53, Tumor, Solid.
Sponsors: Virginia Commonwealth University, Aprea Therapeutics, BioMed Valley Discoveries, Inc.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Massey Cancer Center, Virginia Commonwealth University has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massey Cancer Center, Virginia Commonwealth University has 4 clinical trials on record. Their work covers Epithelial Cancer, Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53, Tumor, Solid.
Yes — Massey Cancer Center, Virginia Commonwealth University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.